Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 April 2018 Photo Supplied
UFS Debate Society to compete in upcoming World Championships

The UFS Debate Society is a diverse, cross-boundary team of UFS students who are not strangers to success, and who are exceptionally brilliant at what they do. Before winning the largest open debating competition in Africa in 2018, the team had qualified and competed in the finals for three consecutive years since 2015. The society has now been selected to compete in the Cape Town Open Debating Competition this coming weekend from 27 to 29 April, in a build-up to the World Championships taking place in December 2018.

According to the UFS Debate Society Chairperson, Tshiamo Malatji: “Thinking artistically about debating requires one to make use of creative reasoning, and essentially, lateral thinking is of importance, even in your everyday life conversations, because you will never fundamentally agree with someone who has opinions which are opposed to yours, but you will be able to appreciate where they are coming from.”

The team is also involved in organising dialogues on our Bloemfontein Campus, such as the Student Rights Dialogue, which brings together various stakeholders of the university for a discussion about human rights. They also conduct debating workshops and, together with the Department of Basic Education, function as judges for debates in the broader Bloemfontein community for less advantaged schools in Botshabelo, Thaba Nchu, Tweespruit, and Dewetsdorp.

The Debate Society is set to host a Global Politics Seminar that will analyse and explain the forces that influence international politics, and South Africa's standpoint in the global perspective. This seminar, taking place in October, will focus on the activities of chief global actors, and some of the core crises that can shape students’ understanding of current foreign affairs. The seminar will comprise presentations from knowledgeable local students and Debate Society alumni, which will conclude with a fiery debate by the society on the dynamic and controversial topic of South Africa's future in the international political arena. 

Access to the seminar is reserved for donors who will pledge their support to the society’s journey to the upcoming World Championships. For more information on how to pledge, visit the World Championships Pledge.

Caption:

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept